Document Detail

The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
MedLine Citation:
PMID:  8847055     Owner:  NLM     Status:  MEDLINE    
BACKGROUND/AIMS: A long-term study and follow-up of an uniform treatment strategy for esophageal varices was evaluated to plan future strategies more effectively. MATERIAL AND METHODS: Morbidity and mortality in 101 patients with liver cirrhosis followed up for 5 years in a single center after the first detection of oesophageal varices were studied. RESULTS: Definitive hemostasis of the first variceal bleeding episode could not be obtained in 31.5%, despite emergency endoscopic sclerotherapy in combination with vasopressin and/or balloon tamponade. Mortality related to this bleeding was 26% in this cohort of patients. Overall mortality from variceal bleeding during the 5 year period was 38%. Death occurred predominantly in patients with advanced liver disease, since the Child-Pugh score of patients who bled and survived was 8 +/- 2 as compared to 11 +/- 2 (p<0.01) in those who bled and died. If fundic varices were the origin of the hemorrhage, the mortality reached 78% within 6 months. Eighty-five percent of the fatalities were related to the liver disease. Besides variceal bleeding, infection was the predominant trigger leading to liver failure; occurring in 25%. The cause of non-liver related death was malignancy of esophagus, lung and pancreas. Only 13% of the patients with liver failure had undergone an orthotopic liver transplantation. CONCLUSION: Since variceal hemorrhage still carries a high mortality rate, primary prophylaxis for patients at high risk is indicated. The systematic, concomitant use of vasoactive drugs to sclerotherapy and the early performance of TIPS in case of failure of sclerotherapy have to be evaluated. Finally patients with an advanced liver disease and increased risk factors for variceal bleeding should be considered earlier for liver transplantation.
F Nevens; L Broeckaert; P Rutgeerts; W Van Steenbergen; J Fevery
Related Documents :
19559425 - Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastr...
8780575 - Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosi...
18291735 - Prevention of recurrent variceal bleeding.
18353385 - Surgical outcomes after modified antegrade scrotal sclerotherapy: a prospective analysi...
15803265 - Catheter ablation of junctional ectopic tachycardia in children, with preservation of a...
11330655 - A risk-benefit assessment of sildenafil in the treatment of erectile dysfunction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hepato-gastroenterology     Volume:  42     ISSN:  0172-6390     ISO Abbreviation:  Hepatogastroenterology     Publication Date:    1995 Nov-Dec
Date Detail:
Created Date:  1996-10-24     Completed Date:  1996-10-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8007849     Medline TA:  Hepatogastroenterology     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  979-84     Citation Subset:  IM    
Department of Hepatogastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Detergents / therapeutic use
Esophageal and Gastric Varices / epidemiology*,  etiology,  therapy
Felypressin / therapeutic use
Follow-Up Studies
Gastrointestinal Hemorrhage / epidemiology*,  etiology,  therapy
Hemostatics / therapeutic use
Liver Cirrhosis / complications,  epidemiology*
Middle Aged
Polyethylene Glycols / therapeutic use
Portasystemic Shunt, Surgical
Sclerosing Solutions / therapeutic use
Survival Rate
Time Factors
Treatment Outcome
Reg. No./Substance:
0/Detergents; 0/Hemostatics; 0/Polyethylene Glycols; 0/Sclerosing Solutions; 56-59-7/Felypressin; 9002-92-0/polidocanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bile leak after T-tube removal--a scintigraphic study.
Next Document:  Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic...